Fora Capital, LLC Lantheus Holdings, Inc. Transaction History

Fora Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$55.54 - $72.65 $200,610 - $262,411	-3,612 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$24.28 - $56.64 $87,699 - $204,583	3,612 New	3,612 $202,000
Q2 2021 Aug 16, 2021	SELL	$19.51 - $27.64 $87,541 - $124,020	-4,487 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$13.77 - $21.66 $14,334 - $22,548	1,041 Added 30.21%	4,487 $96 Million
Q4 2020 Feb 12, 2021	BUY	$10.75 - $14.91 $14,168 - $19,651	1,318 Added 61.94%	3,446 $46,000
Q2 2020 Aug 14, 2020	SELL	$10.34 - $15.51 $3,174 - $4,761	-307 Reduced 12.61%	2,128 $30 Million
Q1 2020 May 15, 2020	BUY	$9.11 - $20.05 $22,182 - $48,821	2,435 New	2,435 $31,000

538

68.4M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.7B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.